|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/70 | (2006.01) |
| A61K 9/16 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 2139494 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08732695.5 |
| Date of filing the European patent application | 2008-03-21 | |
| (97) | Date of publication of the European application | 2010-01-06 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-11 |
| (46) | Date of publication of the claims translation | 2020-05-25 |
| (86) | Number | PCT/US2008/057888 |
| Date | 2008-03-21 |
| (87) | Number | WO 2008/116179 |
| Date | 2008-09-25 |
| (30) | Number | Date | Country code |
| 896286 P | 2007-03-22 | US |
| (72) |
BINDRA, Dilbir, S., US
DALI, Mandar, V., US
PARAB, Prakash, V., US
PATEL, Jatin, M., US
TAO, Li, US
TEJWANI, Ravindra, W., US
VATSARAJ, Nipa, US
WU, Yongmei, US
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Farmacinės kompozicijos, kurių sudėtyje yra dapagliflozino propileno glikolio hidrato |
| PHARMACEUTICAL FORMULATIONS CONTAINING DAPAGLIFLOZIN PROPYLENE GLYCOL HYDRATE |
| Payment date | Validity (years) | Amount | |
| 2025-02-18 | 18 | 347.00 EUR |
| 2026-03-21 |